Search - tctmd.com

Displaying 421 - 440 of 1378

Sort: Relevancy | Date

Presentation TCT 2016

Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes

Presenter: Dmitriy N. Feldman, Emmanouil S. Brilakis

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Presenter: Philip M. Urban, Stephen G. Worthley, Christian M. Spaulding

November 01, 2016

Presentation TCT 2016

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

Presenter: Philip M. Urban, Stephen G. Worthley, Sigmund Silber

November 01, 2016

Presentation TCT 2016

TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials

Presenter: Serban Puricel, Clemens von Birgelen

November 01, 2016

Presentation TCT 2016

TCT 263: Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents

Presenter: Kevin J. Beatt, Frederick Feit

October 31, 2016

Presentation TCT 2016

Self-Expanding Stentys Stent In Various Anatomic Subsets: Evidence Of Clinical Benefit?

Presenter: Chaim S. Lotan, Giora Weisz, Francesco Prati

October 31, 2016

Presentation TCT 2016

Acute MI/SVGS/Thrombus Containing Lesions: Mesh-Covered Mguard Prime

Presenter: Chaim S. Lotan, Giora Weisz

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

Presentation TCT 2016

Small Vessels: Svelte Stent On A Wire

Presenter: Chaim S. Lotan, Giora Weisz, Jordan Safirstein

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents IV: Nile

Presenter: Chaim S. Lotan, Giora Weisz, Ivo Petrov

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents III: Bioss

Presenter: Chaim S. Lotan, Giora Weisz, Robert J. Gil

October 31, 2016

Presentation TCT 2016

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

Presenter: Thomas F. Luscher, Patrick W. Serruys, Alaide Chieffo

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents II: Axxess

Presenter: Chaim S. Lotan, Giora Weisz, Christophe Dubois

October 31, 2016

Presentation TCT 2016

Bifurcation/Left Main Stents I: Tryton

Presenter: Chaim S. Lotan, Giora Weisz, Philippe Généreux

October 31, 2016

Presentation TCT 2016

Dedicated Stents for Specific Scenarios: Historical Perspectives and Stuttering Progress

Presenter: Chaim S. Lotan, Giora Weisz, Martin B. Leon

October 31, 2016

Presentation TCT 2016

B Braun - ISAR Coroflex

Presenter: Marie-Claude Morice, Christian Hengstenberg

October 31, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

Presentation TCT 2016

Alvimedica - Cre8: Design Specifications and Results

Presenter: Marie-Claude Morice, Gennaro Sardella

October 31, 2016

Presentation TCT 2016

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

Presenter: Marie-Claude Morice, Philip M. Urban

October 31, 2016

Presentation TCT 2016

Medtronic Drug-Filled Stent: 6-Month Results From Revelution

Presenter: Marie-Claude Morice, Stephen G. Worthley

October 31, 2016

Advertisement

Bare Metal and 1st Generation Drug-Eluting Stents: Devices, Indications, and Outcomes

Highlights (And my Interpretations) From: Polymer-free DES - LEADERS-free 2-year and RevElution

Highlights (And my Interpretations) From: DES Comparisons BIO-RESORT (TWENTE III) and BIONICS

TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials

TCT 263: Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents

Self-Expanding Stentys Stent In Various Anatomic Subsets: Evidence Of Clinical Benefit?

Acute MI/SVGS/Thrombus Containing Lesions: Mesh-Covered Mguard Prime

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

Small Vessels: Svelte Stent On A Wire

Bifurcation/Left Main Stents IV: Nile

Bifurcation/Left Main Stents III: Bioss

DELTA 2: A Prospective, Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease

Bifurcation/Left Main Stents II: Axxess

Bifurcation/Left Main Stents I: Tryton

Dedicated Stents for Specific Scenarios: Historical Perspectives and Stuttering Progress

B Braun - ISAR Coroflex

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Alvimedica - Cre8: Design Specifications and Results

Biosensors Biofreedom/Cordis Lumeno: Angiographic/Clinical Outcomes And Further Worldwide Development Strategy

Medtronic Drug-Filled Stent: 6-Month Results From Revelution

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content